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TinctureAbstract Psidium guajava is a Myrtaceae plant whose medicinal properties are recognized in sev-
eral locations. The use of teas and tinctures prepared from their leaves has been used to combat
infections caused by fungi of the genus Candida. In this study, aqueous extracts of leaves and
hydroethanolic were tested to verify the antifungal potential and its chemical composition has been
investigated. The microbiological assays were performed by broth microdilution to determine the
minimum inhibitory concentration (MIC) and from these the minimum fungicidal concentration
was performed (MFC) by subculturing on solid media. A cell viability curve was obtained for
demonstration of inhibition of fungal growth of strains of Candida albicans and Candida tropicalis.
Tests to check morphological changes by the action of the extracts were performed in microcultive
cameras depleted environment at concentrations of MIC/2, MIC and MIC  2. Extracts analyzed
by high performance liquid chromatography demonstrated ﬂavonoids and phenolic acids. The
extracts showed fungistatic effect and no fungicide with MIC >8192 lg/mL, MFC above
8192 lg/mL. The IC50 was calculated ranging from 1803.02 to 5623.41 lg/mL. It has been found
Phenolic composition and medicinal usage of Psidium guajava Linn 303that the extracts affect the morphological transition capability, preventing the formation of pseudo-
hyphae and hyphae. Teas and tinctures, therefore, have the potential antifungal, by direct contact,
causing inhibition of fungal multiplication and its virulence factor, the cell dimorphism, preventing
tissue invasion. Further studies are needed to elucidate the biochemical pathways and genes assets
involved in these processes.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Microorganisms of the genus Candida can be found naturally
composing the microbiota of the human organism inhabiting
your gastrointestinal tract and mucous membranes (Lu et al.,
2014; Shao et al., 2007). Changes in dynamic of the host organ-
ism too favor the proliferation of these fungi and the distur-
bance caused in homeostasis can lead to a range of
infections that range in their level and location and can only
be superﬁcial, in skin and mucosal (oral, vaginal candidiasis)
or systemic, compromising the life of an individual (Mayer
et al., 2013; Sardi et al., 2013).
Usually the infections caused by Candida spp. in its magni-
tude are assigned to the species Candida albicans, however, ill-
ness caused by Candida non-albicans (CNAM) had increased
incidence over the years and yeasts of Candida glabrata, Can-
dida tropicalis, Candida krusei and Candida parapsilosis have
been increasingly identiﬁed as human pathogens (Sardi et al.,
2013; Silva et al., 2012).
Mechanisms of resistance to commercial drugs developed
by these microorganisms have been constantly investigated
and reported and the continuous evolution for resistance is
extremely worrying considering the limited number of antifun-
gal classes currently available (Maubon et al., 2014; Xie et al.,
2014). The search for different therapeutic alternatives is a
constant and the use of natural products of plant origin often
serves as a reference to the search for active compounds and, in
this sense, a ethno directed approach has directed pharmaceu-
tical research (Albuquerque and Hanazaki, 2006), in this case,
in order to antifungal discovery potential.
Member of the Myrtaceae, Psidium guajava Linn. species
(guava), plant native to tropical America (Okamoto et al.,
2009), has its widespread medicinal use among the world’s
populations. Being a plant of tropical and subtropical regions,
can be found on plantations, in backyards of homes, or natu-
rally in other areas, and could even be considered invasive spe-
cies (Richardson and Rejma´nek, 2011).
The medicinal attributes from all parts of the species are
spread over several generations and therefore, make up many
lists of ethnobotanical studies, showing great versatility and
value in use, being mentioned for the treatment of various
types of diseases (Dakappa-Shruthi et al., 2013; Gutie´rrez
et al., 2008).
This therapeutic use recorded in different locations includes
a signiﬁcant number of body systems such as disorders of the
sensory system: vertigo (Dakappa-Shruthi et al., 2013;
Gutie´rrez et al., 2008); disorders of the respiratory system:
laryngitis, sore throat, colds, coughs, tuberculosis, lung prob-
lems, bronchitis, catarrh, rhinitis (Dakappa-Shruthi et al.,
2013; Gutie´rrez et al., 2008; Ogbole and Ajaiyeoba, 2010;
Waruruai et al., 2011); disorders of the genito-urinary system:
menstrual disorders, vaginal discharge, childbirth, nephritis,premenstrual syndrome, gonorrhea, non-speciﬁed venereal dis-
eases, leucorrhea (Dakappa-Shruthi et al., 2013; Gutie´rrez
et al., 2008; Van Vuuren and Naidoo, 2010); disorders of the
nervous system: anorexia, epilepsy, cerebral ailments, chorea,
convulsions, nervousness (Dakappa-Shruthi et al., 2013;
Go´mez-Estrada et al., 2011; Gutie´rrez et al., 2008); disorders
of the digestive system: diarrhea, dysentery, stomachache,
digestive problems, gastric insufﬁciency, ulcers, dyspepsia, gas-
troenteritis, gastritis, bowel disorders, colic, toothache, consti-
pation (Dakappa-Shruthi et al., 2013; Go´mez-Estrada et al.,
2011; Gutie´rrez et al., 2008); disorders of the circulatory sys-
tem: piles, swelling, hypertension, edema (Dakappa-Shruthi
et al., 2013; Gutie´rrez et al., 2008); the musculoskeletal system
and connective tissue diseases: gout, spasm, rheumatic pain
(Dakappa-Shruthi et al., 2013; Gutie´rrez et al., 2008); not
deﬁned conditions or pain not deﬁned: aches (Dakappa-
Shruthi et al., 2013); skin diseases and tissue subcutaneous:
inﬂamed mucous membranes, mouth – swelling, skin problems,
ulcers, itch, scabies, skin sores, wounds, dermatosis, sores, boil,
gingivitis (Dakappa-Shruthi et al., 2013; Gutie´rrez et al., 2008);
diseases of the endocrine glands, nutrition andmetabolism: dia-
betes (Gutie´rrez et al., 2008); infectious and parasitic diseases:
cholera, worms, bacterial infections, herpes, mycoses, thrush,
pox, measles (Dakappa-Shruthi et al., 2013; Gutie´rrez et al.,
2008; Waruruai et al., 2011); neoplasms: cancer (Alonso-
Castro et al., 2011), and disease of the blood and blood-
forming organs: hemorrhages, blood cleansing (Dakappa-
Shruthi et al., 2013; Gutie´rrez et al., 2008).
The P. guajava is popularly used in the treatment of infec-
tious diseases, particularly against those caused by fungi, it is
common practice registered in different countries such as Bra-
zil, Cuba and South Africa where it is used to treat thrush, leu-
corrhoea, and vaginitis, pathologies associated with infections
caused by Candida spp. (Borba and Macedo, 2006; Fenner
et al., 2006; Oliveira et al., 2010; Ramı´rez et al., 2007; Van
Vuuren and Naidoo, 2010).
Considering the pharmacological potential of the species P.
guajava described in ethnobotanical reports, especially with
regard to its therapeutic use in treatments against diseases
caused by fungi, this study aims to scientiﬁcally validate the
antifungal properties of tea and tincture prepared with leaves
of guava and evaluate the effect of natural products in viru-
lence strains of C. albicans and C. tropicalis, particularly its
morphological transition process.2. Material and methods
2.1. Collection area
The collection was realized in the rainy season at the county of
Milagres, Ceara´, Northeastern region of Brail (07 17.1190 S
304 M.F.B. Morais-Braga et al.and 038 51.7790 W, 388 m of altitude; 07 17.1200 S and
038 51.7780 W, 389 m of altitude; 07 17.1220 S and 038
51.7760 W, 392 m of altitude; 07 17.1190 S and 038 51.7790
W, 388 m of altitude) at ‘‘Sı´tio” Malhada. The climate is
semi-arid, with temperatures ranging between 24 and 26 C
(IPECE, 2013).
2.2. Plant material
The study was conducted using young, healthy leaves of a
Psidium species locally known as red guava, which were col-
lected and transported to the Laboratory of Microbiology
and Molecular Biology at the Regional University of Cariri
– URCA. Twigs with ﬂowers of the species were also collected
and vouchers were produced and deposited in the Herbarium
Da´rdano de Andrade Lima at the university under No.
10935, where the species was identiﬁed as Psidium guajava
Linn. The collection period included January, February,
March and April, known as the ‘‘wintry block of the Cariri
Ceara region.” Collections were made between 8:30 and
10:30 am, and the plant material was taken to the laboratory
where it was subjected to qualitative screening and cleaning
before being weighed and stored under refrigeration. Alto-
gether, there was 2650 g of leaves in perfect condition, and this
quantity was divided for preparation of three types of extracts:
Aqueous Extract of P. guajava Infusion (AEPGI), Aqueous
Extract of P. guajava Decoction (AEPGD) and: Hydroethano-
lic Extract of P. guajava (HEPG).
2.3. Preparation of extracts
2.3.1. Aqueous extracts
Two types of aqueous extracts were prepared, each using
399.9 g of leaves mixed with 6 L of water (based on a propor-
tion of 10 g/150 mL, equivalent to one cup of tea – 150 cc).
The decoction was made by mixing roughly cut leaves in cold
water and then boiling for 15 min. Afterward, the tea was
allowed to cool, ﬁltered and then stored under refrigeration.
As for the infusion, the water was boiled without leaves,
which were placed in the water after turning off the heat.
The pot was covered with a lid and allowed to stand until
the tea cooled down (Matos, 2002), and the preparation
was then ﬁltered and stored under refrigeration and both
infusion and decoction were frozen (60 C) and lyophilized
to dryness. The powdered extracts were stored under refriger-
ation for testing, using 14.46 g (yield 3.62%) and 15 g (yield
3.75%) extract powder from the decoction and infusion,
respectively.
2.3.2. Hydroethanolic extract
The hydroethanolic extract (70%) was prepared by trituration
with cold extraction, using a total of 1846.5 g leaves in a pro-
portion of 5 g/mL of hydroethanolic solution (Matos, 2002).
The leaves were cut to increase contact surface with the sol-
vent, and the mixture was left at room temperature protected
from air and light, for a period of 96 h for maximum extrac-
tion efﬁciency. The mixture was then ﬁltered and placed in a
rotary evaporator (Q-344B – Quimis – Brazil) at 40 rpm and
60 C to concentrate the extract. Finally, the crude extract
was frozen, lyophilized (50.8 g – yield 2.75%) and then stored
under refrigeration.2.4. Chemical analysis
2.4.1. Chemical, apparatus and general procedures
All chemicals were of analytical grade. Methanol, acetic acid,
gallic acid, caffeic acid and chlorogenic acid were purchased
from Merck (Darmstadt, Germany). Quercetin, quercitrin, iso-
quercitrin, rutin, kaempferol, luteolin, catechin and epicate-
chin were acquired from Sigma Chemical Co. (St. Louis,
MO, USA). High performance liquid chromatography
(HPLC–DAD) was performed with a Shimadzu Prominence
Auto Sampler (SIL-20A) HPLC system (Shimadzu, Kyoto,
Japan), equipped with Shimadzu LC-20AT reciprocating
pumps connected to a DGU 20A5 degasser with a CBM
20A integrator, SPD-M20A diode array detector and LC solu-
tion 1.22 SP1 software.
2.4.2. High performance liquid chromatography with diode array
detection (HPLC–DAD)
Reverse phase chromatographic analyseswere carried out under
gradient conditions using C18 column (4.6 mm  250 mm)
packed with 5 lm diameter particles; the mobile phase was
water containing 2% acetic acid (A) and methanol (B), and
the composition gradient was: 5% (B) for 2 min; 25% (B) until
10 min; 40, 50, 60, 70 and 80% (B) every 10 min; following the
method described by Silva et al. (2014) with slightmodiﬁcations.
P. guajava extracts (hydroethanolic – EHEPG, infusion – EAIPG
and decoction – EADPG) and mobile phase were ﬁltered
through 0.45 lmmembrane ﬁlter (Millipore) and then degassed
by ultrasonic bath prior to use, the extracts of P. guajava were
analyzed at a concentration of 20 mg/mL. The ﬂow rate was
0.6 mL/min and the injection volume was 50 lL. The sample
andmobile phase were ﬁltered through 0.45 lmmembrane ﬁlter
(Millipore) and then degassed by ultrasonic bath prior to use.
Stock solutions of standard references were prepared in
water: methanol (1:1; v/v) at a concentration range of
0.025–0.300 mg/mL catechin, epicatechin, quercetin, quercitrin,
isoquercitrin, kaempferol, luteolin and rutin, and 0.035–
0.300 mg/mL for gallic, caffeic and chlorogenic acids. Quantiﬁ-
cation was carried out by integration of the peaks using the
external standard method, at 254 nm for gallic acid, 281 nm
for catechin and epicatechin, 327 nm for chlorogenic and caffeic
acids, and 366 for quercetin, quercitrin, isoquercitrin, luteolin,
kaempferol and rutin. The chromatography peaks were con-
ﬁrmed by comparing its retention time with those of reference
standards andbyDADspectra (200–500 nm). Calibration curve
for gallic acid:Y= 12673x+ 1281.9 (r= 0.9998); caffeic acid:
Y= 12943x+ 1191.7 (r= 0.9996); chlorogenic acid:
Y= 12083x+ 1327.9 (r= 0.9995); catechin: Y= 11734x+
1306.8 (r= 0.9999); epicatechin: Y= 12387x+ 1239.1
(r= 0.9997); rutin: Y= 13752x+ 1186.5 (r= 0.9991); quer-
cetin: Y= 11970x+ 1181.7 (r= 0.9996); quercitrin:
Y= 11679x+ 1251.7 (r= 0.9998), isoquercitrin:
Y= 13759x+ 1251.9 (r= 0.9993), kaempferol: Y= 12659x
+ 1172.3 (r= 0.9997) and luteolin: Y= 12507x+ 1341.8
(r= 0.9990). All chromatography operations were carried out
at ambient temperature and in triplicate.
2.4.3. Limit of detection (LOD) and limit of quantification
(LOQ)
LOD and LOQ were calculated based on the standard devia-
tion of the responses and the slope using three independent
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and LOQ were calculated as 3.3 and 10 r/S, respectively,
where r is the standard deviation of the response and S is
the slope of the calibration curve.
2.5. Antifungal assay
2.5.1. Strains and culture media used
Standard types of strains were obtained from the Culture Col-
lection of Oswaldo Cruz of the Brazilian Institute of Quality
Control in Health (INCQS) and clinical isolates of the yeasts
C. albicans and C. tropicalis were provided by Dr. Edeltrudes
Oliveira Lima (Mycology Laboratory of Paraı´ba Federal
University), namely CA INCQS 40006, CA LM 62, CA LM
77, CA LM 109, CA LM 111, CA LM 122, CT INCQS
40042, CT LM 18, CT LM 20 and CT LM 23. These strains
were inoculated into Sabouraud Dextrose Agar (SDA,
KASVI) and incubated for 24 h at 37 C. Afterward, small ali-
quots of yeast were transferred to test tubes each containing
3 mL of sterile saline (0.9%). Using the McFarland scale, the
concentration of the inoculum was standardized by comparing
its turbidity with the 0.5 standard, giving a standard yeast sus-
pension of 1  105 cells/mL (NCCLS, 2002). The inocula thus
prepared were used to determine the minimum inhibitory con-
centration (MIC) in Sabouraud Dextrose Broth (SDB, HIME-
DIA), double concentrated. Another culture medium was used
for analysis of yeast micromorphology. The potato dextrose
agar (PDA, DIFCO) was prepared by diluting it more than
that recommended by the manufacturer to make it a depleted
medium capable of stimulating yeast to produce hyphae. Agar
was added to this diluted medium to obtain a solid medium.
2.5.2. Drugs, reagents and preparation of solutions
Dimethyl sulfoxide (DMSO, Merck, Darmstadt, Germany)
was used for dilution of the extracts, and the antifungalFigure 1 Chromatogram of Psidium guajava extracts. High perform
Psidium guajava. (A) Hydroethanolic Extract of P. guajava (HEPG); (
Extract of P. guajava Infusion (AEPGI); gallic acid (peak 1), catechin (p
(peak 5), rutin (peak 6), quercitrin (peak 7), isoquercitrin (peak 8), quﬂuconazole (Capsule – FLUCOMED), diluted in water, was
used as the reference drug. The matrix solutions of the extracts
were prepared by weighing 0.3 g of each extract and then dilut-
ing in 1 mL of DMSO. To obtain the desired concentration for
testing, the extracts were further diluted in sterile distilled water
so that the concentration of DMSO in the natural product did
not exert any activity in the test cells (Stoppa et al., 2009).
2.5.3. Microbiological screening
Microbiological screening was performed to select the yeasts to
be used in microbiological testing. The microdilution broth
was chosen to perform this procedure, and this was done by
determining the MIC (Javadpour et al., 1996), since the plates
prepared to carry out this test would be used later in tests to
ﬁnd the minimum fungicidal concentration, besides facilitating
the demonstration of cell viability curve and calculating the
IC50 of the test products.
2.5.4. Determination of minimum inhibitory concentration
(MIC)
This test was performed by the broth microdilution method in
96-well plates. Each well was ﬁlled with 100 lL of SDB con-
taining 10% fungal inoculum, and then, 100 lL of the natural
product (16,384 lg/mL) or ﬂuconazole (antifungal reference)
at the same concentration, was added to the ﬁrst well, followed
by twofold serial dilution. The concentrations in the wells ran-
ged from 64 to 8192 lg/mL. The last well contained no extract
or drug and served as the normal growth control (Javadpour
et al., 1996). Controls for diluent of the products (using saline
instead of inoculum) and the sterile medium were also pre-
pared. All tests were performed in triplicate. The plates were
incubated at 37 C for 24 h and afterward read in an ELISA
spectrophotometer (Thermoplate) at a wavelength of
630 nm. The MIC was deﬁned as ‘‘the lower concentration
of na antimicrobial agent that inhibit the visible growth ofance liquid chromatography phenolics and ﬂavonoids proﬁle of
B) Aqueous Extract of P. guajava Decoction (AEPGD); Aqueous
eak 2), chlorogenic acid (peak 3), caffeic acid (peak 4), epicatechin
ercetin (peak 9), kaempferol (peak 10) and luteolin (peak 11).
Table 1 Phenolics and ﬂavonoid composition of Psidium guajava.
Compounds Psidium guajava LOD lg/mL LOQ lg/mL
EHPG mg/g AEPGD mg/g AEPGI mg/g
Gallic acid 3.46 ± 0.01 a 1.57 ± 0.02 a 1.54 ± 0.01 a 0.019 0.062
Catechin 1.57 ± 0.03 b 4.94 ± 0.01 b 1.29 ± 0.02 b 0.008 0.025
Chlorogenic acid 4.39 ± 0.01 c 4.23 ± 0.03 c 1.25 ± 0.03 b 0.024 0.081
Caﬀeic acid 8.01 ± 0.02 d 4.30 ± 0.01 c 4.73 ± 0.01 c 0.035 0.116
Epicatechin 1.58 ± 0.01 b 3.61 ± 0.02 d 3.58 ± 0.02 d 0.010 0.034
Rutin 3.62 ± 0.01 a 3.52 ± 0.01 d 3.97 ± 0.01 e 0.017 0.056
Quercitrin 11.17 ± 0.03 f 4.95 ± 0.01 b 8.62 ± 0.01 f 0.032 0.105
Isoquercitrin 10.35 ± 0.01 e 3.48 ± 0.03 d 8.59 ± 0.03 f 0.009 0.031
Quercetin 16.81 ± 0.02 g 10.15 ± 0.03 e 3.45 ± 0.03 d 0.025 0.083
Kaempferol 8.26 ± 0.03 d 4.32 ± 0.01 c 3.42 ± 0.01 d 0.018 0.059
Luteolin 10.13 ± 0.01 e 1.69 ± 0.03 a 8.51 ± 0.02 f 0.023 0.075
Results are expressed as mean ± S.E. of three determinations. Averages followed by different letters differ by Tukey test at p< 0.01. HEPG:
Hydroethanolic Extract of P. guajava; AEPGD: Aqueous Extract of P. guajava Decoction; AEPGI: Aqueous Extract of P. guajava Infusion;
LOD: limit of detection; LOQ: limit of quantiﬁcation.
Table 2 IC50 (lg/mL) of Psidium guajava extracts against
Candida strains.
Product tested Candida albicans Candida tropicalis
INCQS
40006
LM 77 INCQS
40042
LM 23
AEPGI 3235.94 3890.45 4570.88 4570.88
AEPGD 4797.33 5623.41 5495.41 5128.61
HEPG 1803.02 1905.46 1862.09 1905.46
Fluconazole 76.72 69.09 73.98 58.63
AEPGI: Aqueous Extract of P. guajava Infusion; AEPGD: Aqu-
eous Extract of P. guajava Decoction; HEPG: Hydroethanolic
Extract of P. guajava: INCQS: Instituto Nacional de Controle de
Qualidade em Sau´de; LM: Laborato´rio de Micologia.
306 M.F.B. Morais-Braga et al.na microorganism in dilution assays” (CLSI, 2002). The results
obtained in the ELISA readout were used to construct the cell
viability curve and the IC50 of the extracts of P. guajava.
2.5.5. Determination of minimum fungicidal concentration
(CFM)
For this test, a small sterile rod was placed in each well of the
MIC test plate (except for sterility control). After mixing the
medium in each well, the rod was taken to a large petri dish
containing SDA, streaking its surface and transferring the
solution (medium + inoculum + natural product) for subcul-
ture of yeast and checking cell viability. After 24 h incubation,
the plates were inspected for any formation of colonies of Can-
dida (Ernst et al., 1999, with modiﬁcations). The concentration
at which there was no growth of fungal colonies was consid-
ered the MFC of the natural product.
2.5.6. Effect of natural products on fungal morphology
To determine if the natural product caused any change in fun-
gal morphology, by inhibiting the development of hyphae,
sterile micromorphological chamber slides were prepared forobservation of yeasts. Three milliliters of PDA medium
depleted by dilution were added to chambers, containing the
natural product concentrations MIC/2, MIC and MIC  2.
Aliquots of the inoculi were taken from the petri dishes to
make two parallel steaks on the solid medium, which were then
covered with a sterile coverslip. The chambers were placed in
the incubator for 24 h (37 C) and inspected under a light
microscope using a 40 objective. A camera was attached to
the microscope to capture images. A control for yeast growth
(hyphae stimulated by depleting medium) was performed, as
well as a control with the conventional antifungal ﬂuconazole
for comparative purposes and a control with DMSO at 100%
and 0.5% (the concentration in the natural products used in
the tests). The assays were performed according to Sidrin
and Rocha (2010) and Mendes (2011), with some
modiﬁcations.
2.6. Statistical analysis
The results of the tests were done in triplicate. Data obtained
for each sample and concentration were checked for their nor-
mal distribution and then analyzed by one-way ANOVA by
post hoc Tukey test. EC50 values were obtained by nonlinear
regression for the purpose of interpolating values from stan-
dard curves (using the software Graphpad Prism, v. 5.0) of
the % growth values plotted against concentration and EC50
values are expressed as lg/mL.
3. Results and discussion
The chemical analysis was performed to detect the presence of
phenolic acids and ﬂavonoids, verifying the predominance of
the latter in two extracts. The hydroethanolic extract showed
more efﬁcient as extracting agent, since quantity of compounds
able to extract higher. To the aqueous extracts, exposure to
different temperature times caused no signiﬁcant difference
in the amount of extracted compounds, however the extract
obtained from infusion had a greater abundance of ﬂavonoids
as compared to the decoction. Studies show that can occur
degradation of ﬂavonoids with temperature rise, however, this
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tion between them (Baby et al., 2007; Mello et al., 2010). In
this sense, the decoction longer exposure to elevated tempera-
ture may have been the cause of the reduction of the level of
ﬂavonoids. The major compound differed only in the analysis
of each extract into the aqueous infusion made, which in this
case is the quercitrin, while the other the quercitrin appears
to be the most expressive content. The chromatogram extracts
of the species are shown in Fig. 1, and the results representing
their chromatographic proﬁles in front the parameters used are
detailed in Table 1.
The chemical composition of P. guajava has been widely
investigated and studies have reported that plant extracts are
constituted alkaloids, triterpenoids, tannins, saponins, glyco-
sides, ﬂavonoids, and phenolic compounds and other com-
pounds (Dakappa-Shruthi et al., 2013; Tambe et al., 2014).
A chemical analysis of tea from the leaves of guava (Chang
et al., 2013) highlighted a polyphenol proﬁle in which the main
components were found: quercetin, myricetins, catechin, gallic
and ellagic acids and their derivatives, but the researchers call
attention to differences in chemical composition, stating that
several factors such as time of collection, form of collection
and processing, temperature, among others, may inﬂuence
the outcome of the chemical prospecting.
The data obtained in microdilution test were used for MIC
determination, assembly of cell viability curve and to calculate
the IC50 for each product. The same procedure was performed
with ﬂuconazole. Cell viability curve of microorganisms in
contact with different concentrations of natural products
showed a similar behavior in the screening, which allowed us
a random choice of lines for continuity of the work. Thus,
the standard strains and clinical isolates of C. albicans wereFigure 2 Cell viability curve Candida strains under the effect of Psidiu
Instituto Nacional de Controle de Qualidade em Sau´de; LM: Laborato´
AEPGD: Aqueous Extract of P. guajava Decoction; HEPG: Hydroethselected (CA INCQS 40006 e CA LM 77) and C. tropicalis
(CT INCQS 400042 e CT LM 23). Information is shown in
Table 2 and Fig. 2. The IC50 of products ranged from
1803.02 to 5623.41 lg/mL and cell viability curve image points
the hydroethanolic extract of the species as being the most
effective because it could reduce a higher percentage of
micro-organisms, when compared to the others.
The MIC of the products in this study was determined and
standardized as >8192 lg/mL and cell viability curve, the con-
centration at which it was observed a marked reduction in the
percentage of viable microorganisms. The results of minimum
fungicidal concentration showed that, the concentrations
tested, no extract showed fungicidal effect, since it failed to
remove, but reduce the population of microorganisms of Can-
dida. We found that the antifungal effect seen is fungistatic and
that minimum fungicidal concentration is >8192 lg/mL.
One of the main virulence factors of Candida is the cell
dimorphism, which depends on the environmental conditions
in which micro-organisms are found growing. This condition
dimorphic is characterized by the ability to alter the cellular
morphology, alternating, in a reversible manner, between the
shape of yeast and hyphae or pseudohyphae, by issuing a
structural extension, a ﬁlament, passing a state considered dis-
persive to invasive, respectively, this being a process commonly
observed in candidemia systemic, which can be found in both
morphological types, the yeast and ﬁlamentous at the same
time (Lu et al., 2014).
Based on the results of the MIC, the tests were performed
to verify that the extracts inﬂuenced the morphological transi-
tion of yeast. To this end we prepared a poor environment in
nutrients, where it functioned as stressor of microorganisms,
stimulating their potential dimorphic. In carrying out them guajava. CA: Candida albicans; CT: Candida tropicalis; INCQS:
rio de Micologia; AEPGI: Aqueous Extract of P. guajava Infusion;
anolic Extract of P. guajava.
Figure 3 Controls used in micromorphology tests. Cell forms of Candida: a: pseudohiphae; b: hiphae; c: yeast; 1, 4, 7 and 10: Growth
control; 2, 5, 8 and 11: DMSO 0.05%; 3, 6, 9 and 12: Fluconazole; CA: Candida albicans; CT: Candida tropicalis; INCQS: Instituto
Nacional de Controle de Qualidade em Sau´de; LM: Laborato´rio de Micologia. Images inspected under a light microscope using a 40
objective.
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trol, and demonstrated the feasibility of this morphological
transition allowed by the nutrient poor environment where
the microculture reveals the presence of pseudohyphae, and
hyphae. In another control, DMSO was tested at 100% and
the maximum concentration is able to prevent the morpholog-
ical transition (data not shown). However, to show that the
change does not exert dimorphic yeast, the DMSO was
assayed in concentration contained in dilution of natural prod-
ucts (0.05%), conﬁrmed that the microculture presented
microorganisms in accordance with the growth control. The
reference drug, ﬂuconazole, was also evaluated and, as the
lowest concentration assayed in the test (MIC/2), caused inhi-
bition of emission of ﬁlamentous structures. The images of the
controls are shown in Fig. 3.
The reading of other microcultivations performed with the
extracts in concentrations of 4096, 8192 and 16384 lg/mL
showed that they were able to affect the phenotypic plasticity
of C. albicans and C. tropicalis reducing hyphae andpseudohyphae formation process in so far as their concentra-
tions were increased. At higher concentration, the yeast form
prevailed so that, or not veriﬁed the presence of ﬁlaments, or
these ﬁlaments were signiﬁcantly reduced, as can be seen in
Figs. 4 and 5.
The guava has been used in Brazil for the treatment of oral
diseases, where both the leaves as bark are used in the prepa-
ration of tea (for infusion or decoction) to be swallowed or
swished still warm, with pretensions to combat thrush and
mouth sores, which may be caused by Candida strains
(Borba and Macedo, 2006; Oliveira et al., 2010). In addition,
there is no record that various parts of the plant are used
not only to treat thrush but also for the treatment of
leukorrhea (Fenner et al., 2006), one of the symptoms of
vaginal candidiasis. In South Africa the tea from the leaves
and roots of guava by infusion is prepared for the treatment
of non-speciﬁc venereal diseases (Van Vuuren and Naidoo,
2010) and in Cuba, the use of P. guajava in folk medicine
was also registered against fungi, where parts of the plant
Figure 4 Effect of Psidium guajava extracts on the morphology of Candida albicans. Concentrations MIC/2, MIC and MIC  2 (4096,
8192 and 16384 lg/mL, respectively). Aqueous Extract of P. guajava Decoction (AEPGD): 1–6; Aqueous Extract of P. guajava Infusion
(AEPGI): 7–12; Hydroethanolic Extract of P. guajava (EHPG): 13–18. INCQS: Instituto Nacional de Controle de Qualidade em Sau´de;
LM: Laborato´rio de Micologia. Images inspected under a light microscope using a 40 objective.
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Figure 5 Effect of Psidium guajava extracts on the morphology of Candida tropicalis. Concentrations MIC/2, MIC and MIC  2 (4096,
8192 and 16384 lg/mL, respectively). Aqueous Extract of P. guajava Decoction (AEPGD): 1–6; Aqueous Extract of P. guajava Infusion
(AEPGI): 7–12; Hydroethanolic Extract of P. guajava (EHPG): 13–18. INCQS: Instituto Nacional de Controle de Qualidade em Sau´de;
LM: Laborato´rio de Micologia. Images inspected under a light microscope using a 40 objective.
310 M.F.B. Morais-Braga et al.
Phenolic composition and medicinal usage of Psidium guajava Linn 311are used in the preparation of dye, powder and elixir (Ramı´rez
et al., 2007). Based on these ethnobotanical reports, we can
assume that the main form of therapeutic use P. guajava
against fungi is the topical use, as the natural product is placed
directly on the skin or mucosa, used in mouthwash and gargle,
in sitz baths and even in tea administration, which when taken
favors the contact of the natural product with the intestinal
lumen, where the infection causing microorganisms can be
accommodated.
If we consider the context of this research, a cup of tea
(made by decoction and infusion) with 150 mL of water and
10 g of fresh leaves, will be contained in this volume, just over
4 times the concentration considered as MIC, was able to
reduce the percentage of viable microorganisms by direct con-
tact. The same situation is extended to hydroethanolic extract.
In 150 mL of tincture is contained 25 times the minimum inhi-
bitory concentration. If relate to the preparation of virulence
potential inhibitor in 150 mL of aqueous extracts of plants
have about 2 times the concentration at which the ﬁlamentous
structures of Candida have been reduced. In this same volume
hydroethanolic extract is contained 12 times the inhibitory
concentration dimorphism. Thus a direct contact of tea or
tincture prepared in the above relation not only reduces the
percentage of viable microorganisms, but also disturbs the pro-
cess of morphological yeast transition that remains in place
after the addition of home-made preparations, neutralizing
one of its virulence factors the ability to invade substrates.
Due to the ethnomedicinal use of P. guajava observed both
in the traditional medicine as complementary and alternative
medicine, the plant is now part of the list of medicinal plants
of the World Health Organization (WHO). Based on funda-
mental criteria such as common use in at least two regions
of WHO and satisfactory amount of scientiﬁc data, this orga-
nization has promoted the development of monographs in
which relevant information about this and other species of
medicinal relevance, was made available to the public access
(WHO, 2009). P. guajava also reported in national lists of
medicinal plants in some countries and is covered in public
policy programs focused on primary health care, as occurs,
for example, in Brazil (BRASIL, 2009; RENISUS, 2009).
The belief system of some people, low economic power of
users, the medications available at minimal cost, the lack of
access to another type of therapeutic resource in conﬂict areas
(especially in poor countries), the fact that they are natural
products and considered by some to be more effective than
allopathic medicines and cause side effects or milder side
effects compared to commercial drugs are some of the reasons
given to justify the signiﬁcant use of medicinal plants (Adnan
et al., 2014; Khan et al., 2014; OMS, 2002), including the spe-
cies under study.
Regarding the popular therapy with P. guajava, several fac-
tors can inﬂuence the ﬁnal result of a treatment as a contact
time of natural product with the infection microorganisms,
duration of treatment, methods of use, among others.
Although we are talking about parts of a plant that has its
fruit habitually used in nutrition for human populations from
different locations, the use of tea fresh leaves for infusion has
had its cytotoxic potential investigated. The aqueous extract
intragastric administration in rats of both sexes (doses of 0.2,
2.0 and 20.0 g/day) for prolonged period (six months) resulted
in signs of hepatotoxicity and renal problems as hydronephro-
sis in males and pyelonephritis, and nephrocalcinosis infemales. The LD50 of the extract was more than 20.0 g/kg
(Attawish et al., 1995).
Almeida et al. (2006) evaluated in vitro the cytotoxicity of
tea made by infusing peritoneal macrophages of mice. The
infusion of the leaves was prepared and tested both immedi-
ately as a few hours after preparation. Soon after preparation,
the infusion was added to the culture environment which
exhibited 10% mortality rate, increasing to 31.82% after stor-
age at 4 C for a period of 48 h. After this period, the index
rose to 76.18% revealing that the infusion, therefore, presents
an immunotoxic effect. In this sense, taking tea in the same day
it is prepared can prevent damage being caused to the cells of
the immune system, which, according to the authors, may be
due to ﬂavonoids oxidation and subsequent release of their
derivatives capable to generate radicals free, which would
cause toxicity.
People affected with candidiasis usually present with some
impairment of their immune responses and in this sense, would
be at serious risk, and may further compromise the body’s
defense case, for lack of such risks, adopt an inadequate alter-
native therapy. These studies therefore point to a cautious use
of tea as much as the duration of treatment, preparation and
storage even as the administration of excessive amounts.
The antifungal effect of the species P. guajava reported here
may be due to the presence of phenolic compounds in the
extracts, since they are able to promote both inhibition of
growth of Candida lineages (Alves et al., 2014; Barros et al.,
2013; Candiracci et al., 2011; Tempesti et al., 2012; Vashisth
et al., 2013; Candiracci et al., 2012), as well as their ﬁlamentous
structures resulting from the transition process (Candiracci
et al., 2012; Canonico et al., 2014). The percentage of phenolic
compounds of the hydroethanolic extract was more pro-
nounced compared to aqueous extracts as well as their poten-
tial inhibitor, as can be seen in cell viability curve. However,
further investigations are needed to elucidate the mechanisms
by which act the extracts and which in fact, are the phytochem-
icals contained therein, responsible for the observed effect.
P. guajava, in subsequent studies, had its antifungal poten-
tial investigated obtaining results favorable for different
methodologies (Assunccedil et al., 2013; Jebashree et al.,
2011; Mailoa et al., 2014; Suwanmanee et al., 2014), but this
was the ﬁrst report which was investigated and veriﬁed its
inﬂuence on a virulence factor of Candida.4. Conclusion
The use of teas, pastes, plasters and sitz baths prepared from
leaves of P. guajava (red guava) for different populations
had, in this study, their potential bioactive scientiﬁcally justi-
ﬁed through tests with leaf extracts by direct contact, since,
besides provoking a decrease in the population of micro-
organisms of the genus Candida, affected an important fungal
virulence factors, morphological transition, and consequently
their invasive potential of tissues. The observed antifungal
effect is fungistatic and not fungicidal, since he did not kill
the fungi. However, it is important to remember that the exist-
ing cultural complex systems in these populations allow differ-
ent forms of therapeutic preparations with amounts of
ingredients that may be different from that used in our tests,
it is known that there is no standardization when it comes to
the use of medicinal plants. Further studies are needed to
312 M.F.B. Morais-Braga et al.understand the genetic and biochemical processes involved in
both dynamic fungistatic as in inhibiting emissions of cell
extensions of C. albicans and C. tropicalis in its virulence.
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